Medicines losing patent protection

2026

49 medicines lose their last listed patent or exclusivity in 2026.

January6 medicines

  1. Promactaeltrombopag olamine · Novartis Pharmaceuticals Corp
  2. Promacta Kiteltrombopag olamine · Novartis Pharmaceuticals Corp
  3. Soluprep Schlorhexidine gluconate and isopropyl alcohol · Solventum US LLC
  4. Primatene Mistepinephrine · Armstrong Pharmaceuticals Inc
  5. Revatio · Solution (intravenous)sildenafil citrate · Viatris Specialty LLC
  6. Revatio · For suspension (oral)sildenafil citrate · Viatris Specialty LLC

February3 medicines

  1. Egatentriclabendazole · Novartis Pharmaceuticals Corp
  2. Briviact · Solution (intravenous)brivaracetam · UCB Inc
  3. Briviact · Solution (oral)brivaracetam · UCB Inc

March5 medicines

  1. Arnuity Elliptafluticasone furoate · Glaxosmithkline Intellectual Property Development Ltd England
  2. Naproxen Sodiumnaproxen sodium · Bionpharma Inc
  3. Pradaxadabigatran etexilate mesylate · Boehringer Ingelheim Pharmaceuticals Inc
  4. Rextovynaloxone hydrochloride · Amphastar Pharmaceuticals Inc
  5. Coreg CRcarvedilol phosphate · Waylis Therapeutics LLC

April5 medicines

  1. Treximetnaproxen sodium and sumatriptan succinate · Azurity Pharmaceuticals Inc
  2. Vimpat · Tablet (oral)lacosamide · UCB Inc
  3. Vimpat · Solution (intravenous)lacosamide · UCB Inc
  4. Vimpat · Solution (oral)lacosamide · UCB Inc
  5. Zetiaezetimibe · Organon LLC a sub of Organon and Co

May3 medicines

  1. Lexaproescitalopram oxalate · Abbvie Inc
  2. Gattex Kitteduglutide · Takeda Pharmaceuticals USA Inc
  3. Kuvansapropterin dihydrochloride · Biomarin Pharmaceutical Inc

June6 medicines

  1. Emflaza · Tablet (oral)deflazacort · Ptc Therapeutics Inc
  2. Emflaza · Suspension (oral)deflazacort · Ptc Therapeutics Inc
  3. Cambiadiclofenac potassium · Cosette Pharmaceuticals Inc
  4. Supprelin LAhistrelin acetate · Endo Operations Ltd
  5. Aplenzinbupropion hydrobromide · Bausch Health US LLC
  6. Thiolatiopronin · Mission Pharmacal Co

July6 medicines

  1. Fycompa · Tablet (oral)perampanel · Catalyst Pharmaceuticals Inc
  2. Fycompa · Suspension (oral)perampanel · Catalyst Pharmaceuticals Inc
  3. Opillnorgestrel · Laboratoire Hra Pharma
  4. Spirivatiotropium bromide · Boehringer Ingelheim Pharmaceuticals Inc
  5. Aktenlidocaine hydrochloride · Thea Pharma Inc
  6. Omegavenfish oil triglycerides · Fresenius Kabi USA LLC

August4 medicines

  1. Nuedextadextromethorphan hydrobromide and quinidine sulfate · Otsuka America Pharmaceutical Inc
  2. Tekturnaaliskiren hemifumarate · Lxo Ireland Designated Activity Co
  3. Gallium Ga 68 Edotreotidegallium GA-68 edotreotide · Univ Iowa Hosps and Clinics Pet Imaging Center
  4. Dymistaazelastine hydrochloride and fluticasone propionate · Mylan Specialty LP

September1 medicine

  1. Spryceldasatinib · Bristol Myers Squibb Co

October5 medicines

  1. Veregensinecatechins · Ani Pharmaceuticals Inc
  2. Ariceptdonepezil hydrochloride · Eisai Inc
  3. Saphrisasenapine maleate · Abbvie Inc
  4. Androgeltestosterone · Besins Healthcare Ireland Ltd
  5. Adasuveloxapine · Nova Pneuma Inc

November1 medicine

  1. Naropinropivacaine hydrochloride · Fresenius Kabi USA LLC

December4 medicines

  1. Clindesseclindamycin phosphate · Padagis US LLC
  2. Protonixpantoprazole sodium · Wyeth Pharmaceuticals LLC
  3. Signiforpasireotide diaspartate · Recordati Rare Diseases Inc
  4. Tissuebluebrilliant blue G · Dutch Ophthalmic Research Center International BV